Impact of the Lockdown Due to the COVID-19 Pandemic on Patients With Inflammatory Bowel DiseaseMedicine Published on 2021-12-102022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] 95% CI Active disease affected age Analysis bowel conducted coronavirus disease COVID-19 COVID-19 pandemic Crohn's disease disease Disease activity disorder Effect Enrollment environmental factors exacerbated Factor Follow-up Government hospital IBD illnesses Impact Improving independent Inflammatory bowel disease intestinal Japan lockdown Logistic regression analysis management Mental multivariate Odds ratio outcome pandemic Patient patients Psychological questionnaire reported sleep quality Stress subsequent ulcerative colitis worsened [DOI] 10.3389/fmed.2021.649759 PMC 바로가기 [Article Type] Medicine
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation StrategySupplement Articles Published on 2021-12-052022-10-29 Journal: Journal of the Canadian Association of Gastroenterology [Category] COVID-19, [키워드] Canada Community Consensus coronavirus Course COVID-19 Critical Crohn’s disease Crohn’s disease global pandemic Guidance IBD Immunocompromised Impact impacted individual Inflammatory bowel disease information International knowledge lockdown management medications mental health pandemic physical distancing platform Prevalence provided public health recommendation resource risk stratification SARS-CoV-2 second wave Strategy translation ulcerative colitis unique website World Health Organization’ [DOI] 10.1093/jcag/gwab028 PMC 바로가기 [Article Type] Supplement Articles
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBDSupplement Articles Published on 2021-12-052022-10-29 Journal: Journal of the Canadian Association of Gastroenterology [Category] COVID-19, [키워드] acute respiratory distress age aging Care Chronic illness Comorbidity coronavirus COVID-19 Crohn’s disease database death decrease elderly ENhance expressed extreme General population Health healthcare Hospitalization IBD immune response immune system Impact increase increased risk Inflammatory bowel disease Inflammatory response Influenza information Italy less morbidity and mortality MOST organism Pneumonia reported resources respiratory responses risk robust SARS-CoV-2 SARS-COV-2 infection SARS-CoV2 Satisfaction senescence severe COVID-19 shown syndrome turn ulcerative colitis vaccination Vaccinations while Youth [DOI] 10.1093/jcag/gwab025 PMC 바로가기 [Article Type] Supplement Articles
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines—Biology, Current Evidence and RecommendationsSupplement Articles Published on 2021-12-052022-10-29 Journal: Journal of the Canadian Association of Gastroenterology [Category] COVID-19, [키워드] adverse event anti-TNF approved Canada Chronic diseases Complete COVID-19 COVID-19 infection COVID-19 pandemic Crohn’s disease current death Efficacy Evidence first dose General population groups IBD immune response Immune-mediated Immunosuppressant Impact individual Inflammatory bowel disease International methotrexate National produced receive receiving reducing Regulatory robust SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines second dose shown symptomatic the vaccine therapy These data Trial ulcerative colitis vaccination Vaccine Vaccine development Vaccines were excluded [DOI] 10.1093/jcag/gwab033 PMC 바로가기 [Article Type] Supplement Articles
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology—The Trends of Disease Over TimeSupplement Articles Published on 2021-12-052022-10-29 Journal: Journal of the Canadian Association of Gastroenterology [Category] COVID-19, [키워드] acute respiratory syndrome affecting Canada Canadian coronavirus coronavirus disease COVID-19 COVID-19 pandemic Crohn’s disease effective Epidemiology example General population IBD Immunity Immunocompromised Impact increased risk Inflammatory bowel disease Intervention medication over pandemic public health Region Reproduction number reproductive Research severe COVID-19 severe disease course Spread time Transmission trend ulcerative colitis vaccination variants of concern vector virus [DOI] 10.1093/jcag/gwab029 PMC 바로가기 [Article Type] Supplement Articles
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive SummarySupplement Articles Published on 2021-12-052022-10-29 Journal: Journal of the Canadian Association of Gastroenterology [Category] COVID-19, [키워드] Adults Canada Canadian children Community coronavirus COVID-19 COVID-19 pandemic Crohn’s disease delivery entire spectrum executive Factor Future group Health status health system higher risk highlight IBD immunosuppressive therapies Impact individual infected with SARS-CoV-2 Inflammatory bowel disease information knowledge literature review Mental Model online tool Person physical Physicians platform pregnant provide researchers SARS-CoV-2 severe disease course translation ulcerative colitis [DOI] 10.1093/jcag/gwab027 PMC 바로가기 [Article Type] Supplement Articles
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of LifeSupplement Articles Published on 2021-12-052022-10-29 Journal: Journal of the Canadian Association of Gastroenterology [Category] COVID-19, [키워드] addition anxiety symptom Care Community concern contribute controls coronavirus coronavirus disease COVID-19 COVID-19 pandemic Crohn’s disease Depression Depressive symptoms detrimental disease distress doubling elevated Evolution Factor General population Health highest Hospitalization IBD Impact impairment IMPROVE include increased risk independent of infecting Inflammatory bowel disease life lowest Mental mental health mental health conditions Mortality MOST National outcome pandemic prevalent psychologic Quality Quality of life reduced reduction in risk SARS-CoV-2 shown suffered Treatment ulcerative colitis Uncertainty while women [DOI] 10.1093/jcag/gwab031 PMC 바로가기 [Article Type] Supplement Articles
Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the RiseBasic Science Review Published on 2021-12-052024-09-04 Journal: Inflammatory bowel diseases [Category] 대상포진, [키워드] Crohn disease cytokine signaling Immune-mediated inflammatory disease Janus kinase ulcerative colitis [DOI] 10.1093/ibd/izab135 PMC 바로가기 [Article Type] Basic Science Review
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel DiseaseSupplement Articles Published on 2021-12-052022-10-29 Journal: Journal of the Canadian Association of Gastroenterology [Category] COVID-19, [키워드] acute respiratory syndrome affected Anxiety Care children coronavirus Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) Corticosteroids COVID-19 COVID-19 severity Crohn’s disease death Depression Disease activity effort Epidemiology examined global pandemic group hospital IBD Impact increased risk Inflammation Inflammatory bowel disease less manifestation Manifestations measure medication mental health mild infection Older pandemic pediatrics Pregnancy pregnant preterm delivery Protective provided reduce required resulting SARS-CoV-2 severe COVID-19 significantly ulcerative colitis vaccination [DOI] 10.1093/jcag/gwab030 PMC 바로가기 [Article Type] Supplement Articles
Infliximab rescue therapy in a patient with acute severe ulcerative colitis and coronavirus disease 2019 followed by Escherichia coli 0157:H7 infection: a case report급성 중증 궤양성 대장염 및 코로나바이러스 질환 2019에 이어 대장균 0157:H7 감염 환자에서 Infliximab 구조 요법: 증례 보고Case Reports Published on 2021-12-012022-09-12 Journal: Croatian Medical Journal [Category] 진단, [키워드] administration antibiotic Antibiotic treatment biologic Case report caused clinical response coronavirus disease COVID-19 disease dominant driven by Escherichia coli general condition induce Infection Inflammatory bowel disease infliximab management Mild Necrosis parameter Patient positive risk SARS-CoV-2 SARS-CoV-2-positive patient second serological test severity tested the patient therapy treat treated Treatment ulcerative colitis uremic syndrome [DOI] 10.3325/cmj.2021.62.634 PMC 바로가기 [Article Type] Case Reports